{"id":56944,"name":"CURRAX PHARMACEUTICALS LLC","slug":"currax-pharmaceuticals-llc","state":"TN","country":"United States of America","description":"Specialty pharmaceutical business","totalSpending":780000,"filings":12,"yearlySpending":[{"year":2023,"income":230000},{"year":2024,"income":340000},{"year":2025,"income":210000}],"issues":["PHA"],"firms":["DLA PIPER LLP (US)"],"lobbyists":["JAMES GREENWOOD","ALEX PINSON","JAMIE GREGORIAN","MARGARET MARTIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)","Executive Office of the President (EOP)","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Legislative and regulatory policies and proposals related to obesity treatment, including the Treat and Reduce Obesity Act of 2023.","Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.","Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.","Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.","Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023."],"years":[2023,2024,2025]}